NanoVibronix Inc. is a medical device company that is focused on creating medical products utilizing its proprietary low-intensity, surface acoustic wave technology. The company's patented technology allows for creation of miniature transducers that transmit low-frequency, low-intensity ultrasound through flexible material surfaces. This unique platform may be utilized for a variety of medical applications requiring low cost therapeutic ultrasound qualities. The company's patch-based products include the PainShieldÂŽ and the WoundShieldâ˘, which have gained CE Mark certification. The PainShield also carries FDA clearance. NanoVibronixâ catheter-based products include the UroShield⢠and NG-Shield⢠devices that are both CE mark certified. The Company was founded by Jona Zumeris, Ph.D., an accomplished scientist that invented the Companyâs proprietary low-intensity, surface acoustic wave technology, which allowed it to develop the first ever wearable therapeutic ultrasound devices. Source
No articles found.
Halozyme is a clinical-stage biotechnology company focused on developing and comme...
Halozyme is a clinical-stage biotechnology comp...
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular di...
GenMark Diagnostics (NASDAQ: GNMK) is a leading...
Alzamend Neuroâ˘, Inc. (âAlzamendâ˘â) is a biotechnology company dedicated t...
Alzamend Neuroâ˘, Inc. (âAlzamendâ˘â) is ...
Adverum is a clinical-stage gene therapy company targeting unmet medical need in o...
Adverum is a clinical-stage gene therapy compan...
Halo gives scientists and academics opportunities to connect with industry partner...
Halo gives scientists and academics opportuniti...
Biomerica, Inc. is a global biomedical company that develops, manufactures and mar...
Biomerica, Inc. is a global biomedical company ...
The recognized global leader in neuromodulation devices to treat blindness, the co...
The recognized global leader in neuromodulation...
Join the National Investor Network and get the latest information with your interests in mind.